Issue 6 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

6

June 24, 2005Jun 24, 2005

Free

DOWNLOAD THE PDF

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

Irinotecan And Carboplatin Improve Response In NSCLC

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

Gemcitabine Improves DFS In Resected Pancreatic Cancer

Rosenberg: Immunotherapy May Have Broad Potential

NCI-Approved Clinical Trials

Recent Issues

Volume 52 | Issue 26 - July 02, 2026

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026